Medical screening -- United States -- Cost effectivenessSee also what's at your library, or elsewhere.
Broader terms: |
Filed under: Medical screening -- United States -- Cost effectiveness
Items below (if any) are from related and broader terms.
Filed under: Medical screening -- United States Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy (1995), by United States Congress Office of Technology Assessment Medical Testing and Health Insurance (OTA-H-384; 1988), by United States Congress Office of Technology Assessment Medical Monitoring and Screening in the Workplace: Results of a Survey (Washington: GPO, 1991), by United States Congress Office of Technology Assessment Genetic Tests and Health Insurance: Results of a Survey (1992), by United States Congress Office of Technology Assessment
Filed under: Drug testing -- United States -- CongressesFiled under: Genetic screening -- United States Genetic Counseling and Cystic Fibrosis Carrier Screening: Results of a Survey (1992), by United States Congress Office of Technology Assessment
Filed under: Genetic screening -- Moral and ethical aspects -- United States Genetic Monitoring and Screening in the Workplace (1990), by United States Congress Office of Technology Assessment Filed under: Medical screening -- Moral and ethical aspects -- United States
Filed under: Cost effectiveness
Filed under: Cost effectiveness -- Case studies
Filed under: Angiography -- Digital techniques -- Cost effectivenessFiled under: Cimetidine -- Cost effectivenessFiled under: Cocaine abuse -- United States -- Prevention -- Cost effectivenessFiled under: Continuous ambulatory peritoneal dialysis -- United States -- Cost effectivenessFiled under: Diagnosis -- Cost effectivenessFiled under: Drug abuse -- Study and teaching -- United States -- Cost effectivenessFiled under: Heart, Artificial -- Cost effectivenessFiled under: Influenza -- United States -- Prevention -- Cost effectivenessFiled under: Medical care -- Cost effectiveness The Implications of Cost-Effectiveness Analysis of Medical Technology (1980), by United States Congress Office of Technology Assessment Filed under: Medical instruments and apparatus -- Cost effectiveness Cardiac Radionuclide Imaging and Cost Effectiveness (1982), by William B. Stason and Eric Fortess (PDF files at Princeton) Assessing Selected Respiratory Therapy Modalities: Trends and Relative Costs in the Washington, D.C., Area (1981), by United States Congress Office of Technology Assessment (PDF files at Princeton) The Costs and Effectiveness of Nurse Practitioners (1981), by Lauren LeRoy and Sharon Solkowitz (PDF files at Princeton) The Feasibility of Economic Evaluation of Diagnostic Procedures: The Case of CT Scanning (Washington: Office of Technology Assessment, 1981), by Judith L. Wagner (PDF files at Princeton) Periodontal Disease: Assessing the Effectiveness and Costs of the Keyes Technique (OTA background paper #2, case study #5, for "The Implications of Cost-Effectiveness Analysis of Medical Technology"; 1980), by Richard M. Scheffler and Sheldon Rovin (PDF files at Princeton) Allocating Costs and Benefits in Disease Prevention Programs: An Application to Cervical Cancer Screening (1981), by Bryan R. Luce (PDF files at Princeton) Benefit-And-Cost Analysis of Medical Interventions: The Case of Cimetidine and Peptic Ulcer Disease (1981), by United States Congress Office of Technology Assessment (PDF files at Princeton) Filed under: Medical technology -- Cost effectiveness Cardiac Radionuclide Imaging and Cost Effectiveness (1982), by William B. Stason and Eric Fortess (PDF files at Princeton) Assessing Selected Respiratory Therapy Modalities: Trends and Relative Costs in the Washington, D.C., Area (1981), by United States Congress Office of Technology Assessment (PDF files at Princeton) The Costs and Effectiveness of Nurse Practitioners (1981), by Lauren LeRoy and Sharon Solkowitz (PDF files at Princeton) The Feasibility of Economic Evaluation of Diagnostic Procedures: The Case of CT Scanning (Washington: Office of Technology Assessment, 1981), by Judith L. Wagner (PDF files at Princeton) Periodontal Disease: Assessing the Effectiveness and Costs of the Keyes Technique (OTA background paper #2, case study #5, for "The Implications of Cost-Effectiveness Analysis of Medical Technology"; 1980), by Richard M. Scheffler and Sheldon Rovin (PDF files at Princeton) Allocating Costs and Benefits in Disease Prevention Programs: An Application to Cervical Cancer Screening (1981), by Bryan R. Luce (PDF files at Princeton) Benefit-And-Cost Analysis of Medical Interventions: The Case of Cimetidine and Peptic Ulcer Disease (1981), by United States Congress Office of Technology Assessment (PDF files at Princeton) The Implications of Cost-Effectiveness Analysis of Medical Technology (1980), by United States Congress Office of Technology Assessment
Filed under: Medical technology -- United States -- Cost effectiveness The Implications of Cost-Effectiveness Analysis of Medical Technology (1980), by United States Congress Office of Technology Assessment
Filed under: Medical technology -- United States -- Cost effectiveness -- EvaluationFiled under: Medicine, Preventive -- Cost effectivenessFiled under: Neonatal intensive care -- Cost effectiveness Neonatal Intensive Care for Low Birthweight Infants: Costs and Effectiveness (OTA-HCS-38; 1987), by United States Congress Office of Technology Assessment Filed under: Nurse practitioners -- United States -- Cost effectivenessFiled under: Older people -- Hospital care -- Cost effectivenessFiled under: Older people -- Nursing home care -- Cost effectivenessFiled under: Psychotherapy -- United States -- Cost effectivenessFiled under: Respiratory therapy -- Washington (D.C.) -- Cost effectivenessFiled under: Students -- Drug use -- United States -- Prevention -- Cost effectivenessFiled under: Vaccination -- United States -- Cost effectivenessFiled under: Youth -- Drug use -- United States -- Prevention -- Cost effectivenessMore items available under broader and related terms at left. |